Onesource Specialty Pharma Limited (ONESOURCE) — Announcement | 25 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Audio recording of earnings call made publicly available
💡 Investor Takeaway
Shareholders can now access the full audio of the earnings discussion to assess management commentary and results.

OneSource Specialty Pharma announced that the audio recording of its earnings call discussing unaudited Q1 FY27 results is now available on its website, allowing investors to review the discussion from the July 25, 2026 meeting.

📄 View Original Announcement (PDF)

About Onesource Specialty Pharma Limited (ONESOURCE)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹17,366.55 Cr ROE: -0.8% ROCE: 0.9%

View full ONESOURCE stock details →

📡 Get AI alerts when ONESOURCE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ONESOURCE — Free

📊 More ONESOURCE filings

See all ONESOURCE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ONESOURCE files new disclosures

Track ONESOURCE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ONESOURCE — Free

Free account · 2 AI queries/day